Epidemiology of cytomegalovirus infections. NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Epidemiology of cytomegalovirus infections.

Rev Infect Dis. 1990 Sep-Oct;12 Suppl 7:S701-10. Unique Identifier : AIDSLINE MED/91047536
Ho M; Department of Infectious Diseases and Microbiology, Graduate; School of Public Health, University of Pittsburgh, Pennsylvania.

Abstract: The determinants of cytomegalovirus (CMV) infection and disease can now be understood from studies of newborns, recipients of organ or bone marrow transplants, subjects infected with human immunodeficiency virus, and recipients of blood transfusions. CMV is transmitted to the neonate transplacentally, by passage through a contaminated birth canal, or by ingestion of infected breast milk; to the adult by heterosexual and homosexual sex with an infected partner; and to the transplant recipient by infected organs. A major unsolved problem in the study of CMV is the nature of viral latency. Knowledge regarding the requirements for activation of latent infection at the molecular, cellular, or host level is incomplete. Both viral and host factors may contribute to the successful transmission of CMV by latently infected cells in transplanted organs and transfused blood.
Keywords: Antibodies, Viral/ANALYSIS Blood Transfusion Cytomegalovirus/IMMUNOLOGY Cytomegalovirus Infections/CONGENITAL/*EPIDEMIOLOGY/TRANSMISSION Homosexuality Human HIV Infections/COMPLICATIONS Infant, Newborn Prevalence Sex Behavior Transplantation JOURNAL ARTICLE REVIEW REVIEW, TUTORIALKWDantibodies,viral/analysisbloodtransfusioncytomegalovirus/immunologycytomegalovirusinfections/congenital/KWDepidemiology/transmissionhomosexualityhumanhivinfections/complicationsinfant,newbornprevalencesexbehaviortransplantationjournalarticlereviewreview,tutorial
910228
M9120098

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .